COHANCE
Invest with MTF
Invest Now
Invest in Cohance Lifesciences with 2.86X leverage
Performance
- Low
- ₹379
- High
- ₹397
- 52 Week Low
- ₹379
- 52 Week High
- ₹1,328
- Open Price₹385
- Previous Close₹383
- Volume443,935
- 50 DMA₹545.96
- 100 DMA₹661.20
- 200 DMA₹792.74
Investment Returns
- Over 1 Month -28.15%
- Over 3 Month -56.94%
- Over 6 Month -63.87%
- Over 1 Year -63.29%
Smart Investing Starts Here Start SIP with Cohance Lifesciences for Steady Growth!
Cohance Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 59.7
- PEG Ratio
- 30.6
- Market Cap Cr
- 14,800
- P/B Ratio
- 3.9
- Average True Range
- 16.54
- EPS
- 8.98
- Dividend Yield
- 0
- MACD Signal
- -35.91
- RSI
- 9.94
- MFI
- -
Cohance Lifesciences Financials
Cohance Lifesciences Technicals
EMA & SMA
Current Price
₹386.85
+
3.4
(0.89%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹463.24
- 50 Day
- ₹545.96
- 100 Day
- ₹661.20
- 200 Day
- ₹792.74
Resistance and Support
387.7
- R3 414.05
- R2 405.55
- R1 396.20
- S1 378.35
- S2 369.85
- S3 360.50
Cohance Lifesciences Corporate Actions - Bonus, Splits, Dividends
Cohance Lifesciences F&O
About Cohance Lifesciences
- NSE Symbol
- COHANCE
- BSE Symbol
- 543064
- Managing Director
- Dr. V Prasada Raju
- ISIN
- INE03QK01018
Similar Stocks to Cohance Lifesciences
Cohance Lifesciences FAQs
Cohance Lifesciences share price is ₹386 As on 22 January, 2026 | 23:28
The Market Cap of Cohance Lifesciences is ₹14799.6 Cr As on 22 January, 2026 | 23:28
The P/E ratio of Cohance Lifesciences is 59.7 As on 22 January, 2026 | 23:28
The PB ratio of Cohance Lifesciences is 3.9 As on 22 January, 2026 | 23:28
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.